1. Enhancing Therapeutic Approaches for Melanoma Patients Targeting Epigenetic Modifiers
   Maria Gracia-Hernandez et al, 2021, Cancers CrossRef
2. Defining melanoma combination therapies that provide senolytic sensitivity in human melanoma cells
   Daméhan Tchelougou et al, 2024, Frontiers in Cell and Developmental Biology CrossRef
3. Discovery of BRAF/HDAC Dual Inhibitors Suppressing Proliferation of Human Colorectal Cancer Cells
   Yingjun Li et al, 2022, Frontiers in Chemistry CrossRef
4. Characterization of Vemurafenib-Resistant Melanoma Cell Lines Reveals Novel Hallmarks of Targeted Therapy Resistance
   Martina Radić et al, 2022, International Journal of Molecular Sciences CrossRef
5. Correlation between Autophagy and Drug Resistance of Melanoma BRAF Inhibitors
   添 刘, 2022, Advances in Clinical Medicine CrossRef
6. The Histone Deacetylase Inhibitor ITF2357 (Givinostat) Targets Oncogenic BRAF in Melanoma Cells and Promotes a Switch from Pro-Survival Autophagy to Apoptosis
   Adriana Celesia et al, 2022, Biomedicines CrossRef
7. The mechanism and consequences of BRAF inhibitor resistance in melanoma
   Ksenia Golub et al, 2023, Genome Instability & Disease CrossRef